News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
IACH – Amer Zeidan on the Most Important MDS Studies from ASH24
Photo from Amer Zeidan/LinkedIn
Jan 15, 2025, 05:26

IACH – Amer Zeidan on the Most Important MDS Studies from ASH24

IACH shared on X:

“Join us for the next IACH post ASH24 webinar:

Most Important MDS Studies from ASH24.

Speaker: Prof. Amer Zeidan

Thursday, January 16, 2025
5 PM CET

Register for FREE.”

IACH - Amer Zeidan on the Most Important MDS Studies from ASH24

Amer Zeidan cancer IACH OncoDaily Oncology
Special Coverage
Blog
Jan 15, 2025, 05:26
IACH - Amer Zeidan on the Most Important MDS Studies from ASH24
Blog
Jan 15, 2025, 05:16
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Blog
Jan 15, 2025, 05:06
Cihangir Akyol: Higher lymph node yield improves staging accuracy and prognosis in stage III colon cancer
Blog
Jan 15, 2025, 04:58
David Dellamonica: Take charge of your health - The importance of colorectal cancer screening
Societies
Jan 15, 2025, 04:53
SIOP's Global Health Network Quarterly Business Meeting
Insight
Jan 15, 2025, 04:44
Julie Hallet: Thrilled to announce the launch of CUTNETs Group
Blog
Jan 15, 2025, 04:40
Misinformation on cancer treatment is dangerous, cruel and irresponsible - Canadian Cancer Society
Blog
Jan 15, 2025, 04:29
Charles Swanton: Ultrasensitive ctDNA detection for early-stage NSCLC stratification
Blog
Jan 15, 2025, 04:23
Ann McBrien: Thanks to Tim Kerr for supporting my 5k Your Way Belfast Ormeau 100 Your Way
Blog
Jan 15, 2025, 04:09
Does obesity affect children’s likelihood of survival after being diagnosed with cancer? - ACS Cancer Journal
Insight
Jan 15, 2025, 03:43
Tempus AI Introduced xH: Its First Whole-Genome Sequencing Test
Insight
Jan 15, 2025, 03:32
A Study Found That Minimal Patient Distress Is Associated with Multi-Cancer Early Detection Testing